Futura Medical (FUM) Competitors GBX 9.62 +0.32 (+3.44%) As of 12:01 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock FUM vs. TILS, VSN, HVO, MPH, OBI, ORPH, REDX, ETX, SBTX, and TRXShould you be buying Futura Medical stock or one of its competitors? The main competitors of Futura Medical include Tiziana Life Sciences (TILS), Verseon (VSN), hVIVO (HVO), Mereo BioPharma Group plc (MPH.L) (MPH), Ondine Biomedical (OBI), Open Orphan (ORPH), Redx Pharma (REDX), e-therapeutics (ETX), SkinBioTherapeutics (SBTX), and Tissue Regenix Group (TRX). These companies are all part of the "biotechnology" industry. Futura Medical vs. Tiziana Life Sciences Verseon hVIVO Mereo BioPharma Group plc (MPH.L) Ondine Biomedical Open Orphan Redx Pharma e-therapeutics SkinBioTherapeutics Tissue Regenix Group Futura Medical (LON:FUM) and Tiziana Life Sciences (LON:TILS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, community ranking, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment. Does the media refer more to FUM or TILS? In the previous week, Tiziana Life Sciences had 2 more articles in the media than Futura Medical. MarketBeat recorded 2 mentions for Tiziana Life Sciences and 0 mentions for Futura Medical. Tiziana Life Sciences' average media sentiment score of 0.00 beat Futura Medical's score of -0.47 indicating that Tiziana Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Futura Medical Neutral Tiziana Life Sciences Neutral Which has preferable valuation & earnings, FUM or TILS? Tiziana Life Sciences has lower revenue, but higher earnings than Futura Medical. Futura Medical is trading at a lower price-to-earnings ratio than Tiziana Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFutura Medical£8.68M3.45-£3.88M-£1.21-7.94Tiziana Life Sciences-£3.60M0.00N/A-£16.30N/A Do insiders and institutionals hold more shares of FUM or TILS? 35.7% of Futura Medical shares are owned by institutional investors. 32.1% of Futura Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is FUM or TILS more profitable? Tiziana Life Sciences has a net margin of 0.00% compared to Futura Medical's net margin of -44.64%. Tiziana Life Sciences' return on equity of 0.00% beat Futura Medical's return on equity.Company Net Margins Return on Equity Return on Assets Futura Medical-44.64% -56.44% -26.59% Tiziana Life Sciences N/A N/A N/A Does the MarketBeat Community believe in FUM or TILS? Futura Medical received 66 more outperform votes than Tiziana Life Sciences when rated by MarketBeat users. Likewise, 64.36% of users gave Futura Medical an outperform vote while only 54.30% of users gave Tiziana Life Sciences an outperform vote. CompanyUnderperformOutperformFutura MedicalOutperform Votes18664.36% Underperform Votes10335.64% Tiziana Life SciencesOutperform Votes12054.30% Underperform Votes10145.70% SummaryFutura Medical and Tiziana Life Sciences tied by winning 6 of the 12 factors compared between the two stocks. Get Futura Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for FUM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FUM vs. The Competition Export to ExcelMetricFutura MedicalBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£29.98M£120.73M£5.35B£2.52BDividend Yield4.55%3.69%5.44%4.96%P/E Ratio-7.943.0121.99131.51Price / Sales3.454,236.82396.61225,984.29Price / Cash20.4313.0238.2028.06Price / Book3.7134.726.734.48Net Income-£3.88M-£90.45M£3.21B£5.82B7 Day Performance6.65%2.04%6.43%1.74%1 Month Performance-3.70%-4.97%-5.84%5.14%1 Year Performance-72.94%88.78%15.28%101.62% Futura Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FUMFutura MedicalN/AGBX 9.62+3.4%N/A-73.9%£29.98M£8.68M-7.9412Gap UpTILSTiziana Life SciencesN/AN/AN/AN/A£113.85M£-3,595,000.00-3.5911News CoverageVSNVerseonN/AN/AN/AN/A£112.24MN/A-5.17N/AGap UpHVOhVIVON/AGBX 15.58-4.2%N/A-40.5%£110.21M£68.74M6.42N/AMPHMereo BioPharma Group plc (MPH.L)N/AN/AN/AN/A£89.76MN/A-0.2150Gap DownOBIOndine BiomedicalN/AC$9.50+4.3%N/A+32.1%C$68.31MC$48,596.29-2.86N/AORPHOpen OrphanN/AN/AN/AN/A£67.09M£34.71M-25.30179REDXRedx PharmaN/AN/AN/AN/A£58.35M£4.20M-150.00101Gap UpHigh Trading VolumeETXe-therapeuticsN/AN/AN/AN/A£52.59M£295,000.00-450.0035News CoverageHigh Trading VolumeSBTXSkinBioTherapeuticsN/AGBX 19.50-4.9%N/A+153.0%£44.55M£1.56M-11.9911News CoverageGap UpTRXTissue Regenix GroupN/AGBX 36.490.0%N/A-40.8%£32.90M£31.98M-37.67120 Related Companies and Tools Related Companies TILS Alternatives VSN Alternatives HVO Alternatives MPH Alternatives OBI Alternatives ORPH Alternatives REDX Alternatives ETX Alternatives SBTX Alternatives TRX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:FUM) was last updated on 4/23/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Futura Medical plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Futura Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FUM Stock Free FUM Stock Alerts